GPCR
Structure Therapeutics Inc.
27.60$
-0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +16.0% | +1.3% | – | – | +4.0% | +4.3% | +119.0% | -20.0% | +134.6% | -64.8% | +15.3% | – | – | +24.3% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -162.8% | – | – | – | -177.1% | – | – | – | – | – | – | |
| – | -14.3% | +19.9% | -10.0% | -8.7% | +57.1% | +47.8% | -9.8% | +14.4% | +3.2% | +6.6% | +47.8% | +2.7% | +28.0% | +27.6% | +7.8% | +16.4% | -2.9% | +50.0% | – | |
| – | +32.5% | -15.3% | -6.5% | +30.1% | +41.7% | +1.0% | +31.2% | +26.9% | +3.5% | -0.6% | +17.5% | +2.5% | -1.0% | +17.1% | -6.0% | +18.7% | +30.2% | -18.8% | – | |
| – | -2.4% | +7.8% | -9.1% | +2.1% | +51.7% | +32.3% | +0.6% | +18.5% | +3.3% | +4.1% | +37.6% | +2.7% | +19.7% | +25.1% | +4.7% | -132.5% | – | +34.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -473.7% | – | – | |
| – | +6,786.8% | – | – | – | -29.7% | +66.3% | +0.0% | +239.0% | -37.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -329.1% | – | – | |
| – | -25.9% | +6.7% | +14.1% | -346.6% | – | +372.0% | +243.2% | -177.0% | – | +82.8% | +73.6% | +47.8% | -27.9% | +41.8% | -22.3% | +57.4% | +12.1% | +22.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -330.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -322.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.